Monday, 20 May 2019

Drug Discovery News

  • China, Taiwan firms join hands for cancer drugs

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Mar, 2013

    Singapore: Taiwan's PharmaEngine has signed research collaboration with Guangzhou BeBetter Medicine Technology to design, synthesize and develop new chemical entities against predefined tar...Read more

  • Amgen terminates AstraZeneca psoriasis drug partnership

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 27 May, 2015

    Singapore: Amgen has terminated the partnership with AstraZeneca for co-development and commercialization of brodalumab, an investigational IL-17 inhibitor for patients with moderate-to-sev...Read more

  • UCLA finds new compound to curb Alzheimer's

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Nov, 2012

    Singapore: Researchers at University of California, Los Angeles (UCLA), US, have reported the development of a molecular compound, CLR01, which has been found to prevent toxic proteins from...Read more

  • Dainippon, Nippon Shinyaku sign deal for new drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

    Singapore: Dainippon Sumitomo Pharma (DSP), headquartered in Japan, and Nippon Shinyaku, also a Japanese company, have concluded a license agreement for exclusive rights to develop, manufac...Read more

  • AVEO, Astellas file NDA for tivozanib

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2012

    Singapore: US-based AVEO Oncology and Astellas Pharma have submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) seeking approval for tivozanib in patients wit...Read more

  • Sanofi seeks approval for Lyxumia in Japan

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: Sanofi has submitted the marketing authorization application for Lyxumia, (lixisenatide), an investigational once-daily GLP-1 receptor agonist, to the Ministry of Health, Labour ...Read more

  • Cadila, Swedish firm develop arthritis drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jan, 2014

    Singapore: NovaSAID, part of Sweden-based Karolinska Development, and India- based Cadila Pharmaceuticals have entered into a strategic partnership to develop new treatments for inflammatio...Read more

  • Diabetes drug Actos doubles risk of bladder cancer

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2012

    Singapore: Canadian scientists have revealed that the diabetes drug pioglitazone, also known as Actos, doubles the risk of bladder cancer. However, the researchers found that in absolute te...Read more

  • Taiwan, China firms to co-develop cancer NCEs

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jan, 2013

    Singapore: Taiwan's PharmaEngine has collaborated and signed research agreement with China's Guangzhou BeBetter Medicine Technology. The two companies will collaborate to design, synthesize...Read more

  • Eisai to launch breast cancer drug in India

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

    Singapore: With an agenda to expand its footprint in the emerging markets, Japan's Eisai Pharma is launching its novel anti-cancer drug Eribulin, sold under the brand name of Halaven in Ind...Read more

  • Prana Biotech readies to progress PBT2 to market

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Australia-based Prana Biotechnology is to make senior appointments as it prepares to advance its key drug to treat Alzheimer's and Huntington diseases into late stage and pre-mar...Read more

  • Oramed recruits patients for oral insulin trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

    Singapore: Oramed Pharmaceuticals initiated patient recruitment for a new clinical trial of its orally ingestible insulin capsule,ORMD-0801, for patients with type 1 diabetes mellitus (T1DM...Read more

  • GlobalData: New Zealand focuses on generics

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Feb, 2013

    Singapore: A new study by GlobalData has revealed that New Zealand's Pharmaceutical Management Agency's (PHARMAC) is emphasising on generics, despite the disproportionate growth in elderly ...Read more

  • Allied to soon get CE mark approval from EU

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Feb, 2013

    Singapore: Australia's Allied Healthcare is progressing in the regulatory process for obtaining European CE Mark approval for CardioCel, its lead regenerative tissue product for the repair ...Read more

  • Rockefeller University finds genetic link to autism

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Dec, 2012

    Singapore: A collaborative research effort at Duke University Medical Center and Rockefeller University has pinpointed the precise genetic footprint that links fragile X syndrome and autism...Read more

  • GSK, Theravance COPD drug gets FDA nod

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Apr, 2013

    Singapore: The US FDA's Pulmonary-Allergy Drugs Advisory Committee (PADAC) has approved GlaxoSmithKline (GSK) and Theravance's Breo Ellipta as a once-daily inhaled treatment for the long-te...Read more

  • Bayer gets Japan's nod for gastro tumor drug

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

    Singapore: Bayer has received Japan's approval for Stivarga indicated for the treatment of patients suffering from gastrointestinal stromal tumor (GIST) who have progressed following prior ...Read more

  • Theravance, Alfa Wassermann collaborate

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

    Singapore: Theravance and Alfa Wassermann entered into an exclusive development and commercialization agreement in certain countries for velusetrag, Theravance's investigational 5-HT4 agon...Read more

Podcast

 

Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls